Biotech

All Articles

ArsenalBio raises $325M, pivots away from former lead asset

.Toolbox Biosciences is actually going on up. The cell therapy provider has added $325 thousand in a...

Lilly- backed effective weight loss biotech documents IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually fi...

Aelis' cannabis usage medication flunks phase 2b, steering Indivior to re-think $100M alternative

.Aelis Farma's hopes of getting a quick, positive decision on a $100 million alternative settlement ...

ProKidney standstills stage 3 trial not needed to have for tissue therapy permission

.ProKidney has actually ceased among a set of period 3 trials for its tissue therapy for kidney dise...

Vaxcyte surges on 'spectacular' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what analysts called "spectacular" stage 1/2 records for its own 31-valent pneumoc...

Recursion's brain disease test shows insufficient evidence of efficacy

.Recursion has actually stumbled via a very early test of its own tech-enabled technique to medicine...

Acepodia, Pfizer click on with each other for chemistry-based tissue treatment

.Contact it a case of good chemistry: Acepodia, a biotech based on Nobel Champion scientific researc...

Praxis epilepsy medication decreases confiscations in phase 2 litigation

.Practice Accuracy Medicines has racked up one more midphase gain in epilepsy this year, along with ...

Three officers resign as Dyne messages blended information for DMD prospect

.After running away a scientific grip a number of years back, Dyne Therapy has actually exposed bran...

Arrowhead fires off phase 3 records in rare metabolic illness ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its own hand ahead of a possible showdown along with Ionis, rel...